590 related articles for article (PubMed ID: 34071836)
1. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
Infantino V; Santarsiero A; Convertini P; Todisco S; Iacobazzi V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071836
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
3. HIF-1--a big chapter in the cancer tale.
Ajduković J
Exp Oncol; 2016 Mar; 38(1):9-12. PubMed ID: 27031712
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and cancer cell metabolism.
Huang D; Li C; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
[TBL] [Abstract][Full Text] [Related]
5. Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.
Kim JY; Lee JY
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841148
[TBL] [Abstract][Full Text] [Related]
6. The hypoxia-inducible factor (HIF) couples immunity with metabolism.
Halligan DN; Murphy SJ; Taylor CT
Semin Immunol; 2016 Oct; 28(5):469-477. PubMed ID: 27717536
[TBL] [Abstract][Full Text] [Related]
7. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
Huang LE
Cell Death Differ; 2008 Apr; 15(4):672-7. PubMed ID: 18188166
[TBL] [Abstract][Full Text] [Related]
8. Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis.
Wang X; Zhao D; Xie H; Hu Y
Cancer Lett; 2021 Feb; 499():49-59. PubMed ID: 33217445
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 as a therapeutic target in cancer.
Tang CM; Yu J
J Gastroenterol Hepatol; 2013 Mar; 28(3):401-5. PubMed ID: 23173651
[TBL] [Abstract][Full Text] [Related]
10. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
11. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
12. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
[TBL] [Abstract][Full Text] [Related]
13. Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells.
Park MK; Ji J; Haam K; Han TH; Lim S; Kang MJ; Lim SS; Ban HS
Biomed Pharmacother; 2021 Jan; 133():111082. PubMed ID: 33378978
[TBL] [Abstract][Full Text] [Related]
14. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
15. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
[TBL] [Abstract][Full Text] [Related]
16. Recent agents targeting HIF-1α for cancer therapy.
Hu Y; Liu J; Huang H
J Cell Biochem; 2013 Mar; 114(3):498-509. PubMed ID: 22961911
[TBL] [Abstract][Full Text] [Related]
17. Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia.
Lee GY; Chun YS; Shin HW; Park JW
Oncotarget; 2016 Aug; 7(35):57442-57451. PubMed ID: 27447861
[TBL] [Abstract][Full Text] [Related]
18. A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration.
Ban HS; Xu X; Jang K; Kim I; Kim BK; Lee K; Won M
PLoS One; 2016; 11(9):e0162568. PubMed ID: 27611801
[TBL] [Abstract][Full Text] [Related]
19. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
20. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
